We examined the apoptotic effect of 100 ng/mL TRAIL in combination with 0.25 μM and 0.5 μM paclitaxel, cabazitaxel or docetaxel against PC3 and DU145 prostate cancer cells. The gene discussed is TNFSF10; the disease is prostate carcinoma.